Cargando…

Bosutinib induced pleural effusions: Case report and review of tyrosine kinase inhibitors induced pulmonary toxicity

Tyrosine kinase inhibitors are known to cause pulmonary complications. We report a case of bosutinib related bilateral pleural effusions in a patient with chronic myeloid leukemia. Characteristics of the pleural fluid are presented. We also discuss other tyrosine kinase inhibitors induced pulmonary...

Descripción completa

Detalles Bibliográficos
Autores principales: Moguillansky, Natalia I., Fakih, Hafiz Abdul Moiz, Wingard, John R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435591/
https://www.ncbi.nlm.nih.gov/pubmed/28560147
http://dx.doi.org/10.1016/j.rmcr.2017.05.003
_version_ 1783237239350755328
author Moguillansky, Natalia I.
Fakih, Hafiz Abdul Moiz
Wingard, John R.
author_facet Moguillansky, Natalia I.
Fakih, Hafiz Abdul Moiz
Wingard, John R.
author_sort Moguillansky, Natalia I.
collection PubMed
description Tyrosine kinase inhibitors are known to cause pulmonary complications. We report a case of bosutinib related bilateral pleural effusions in a patient with chronic myeloid leukemia. Characteristics of the pleural fluid are presented. We also discuss other tyrosine kinase inhibitors induced pulmonary toxicities, including pulmonary hypertension and interstitial lung disease.
format Online
Article
Text
id pubmed-5435591
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-54355912017-05-30 Bosutinib induced pleural effusions: Case report and review of tyrosine kinase inhibitors induced pulmonary toxicity Moguillansky, Natalia I. Fakih, Hafiz Abdul Moiz Wingard, John R. Respir Med Case Rep Case Report Tyrosine kinase inhibitors are known to cause pulmonary complications. We report a case of bosutinib related bilateral pleural effusions in a patient with chronic myeloid leukemia. Characteristics of the pleural fluid are presented. We also discuss other tyrosine kinase inhibitors induced pulmonary toxicities, including pulmonary hypertension and interstitial lung disease. Elsevier 2017-05-10 /pmc/articles/PMC5435591/ /pubmed/28560147 http://dx.doi.org/10.1016/j.rmcr.2017.05.003 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Moguillansky, Natalia I.
Fakih, Hafiz Abdul Moiz
Wingard, John R.
Bosutinib induced pleural effusions: Case report and review of tyrosine kinase inhibitors induced pulmonary toxicity
title Bosutinib induced pleural effusions: Case report and review of tyrosine kinase inhibitors induced pulmonary toxicity
title_full Bosutinib induced pleural effusions: Case report and review of tyrosine kinase inhibitors induced pulmonary toxicity
title_fullStr Bosutinib induced pleural effusions: Case report and review of tyrosine kinase inhibitors induced pulmonary toxicity
title_full_unstemmed Bosutinib induced pleural effusions: Case report and review of tyrosine kinase inhibitors induced pulmonary toxicity
title_short Bosutinib induced pleural effusions: Case report and review of tyrosine kinase inhibitors induced pulmonary toxicity
title_sort bosutinib induced pleural effusions: case report and review of tyrosine kinase inhibitors induced pulmonary toxicity
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435591/
https://www.ncbi.nlm.nih.gov/pubmed/28560147
http://dx.doi.org/10.1016/j.rmcr.2017.05.003
work_keys_str_mv AT moguillanskynataliai bosutinibinducedpleuraleffusionscasereportandreviewoftyrosinekinaseinhibitorsinducedpulmonarytoxicity
AT fakihhafizabdulmoiz bosutinibinducedpleuraleffusionscasereportandreviewoftyrosinekinaseinhibitorsinducedpulmonarytoxicity
AT wingardjohnr bosutinibinducedpleuraleffusionscasereportandreviewoftyrosinekinaseinhibitorsinducedpulmonarytoxicity